Effects of Ginger (Zingiber officinale Rosc.) on Decreasing the Production of Inflammatory Mediators in Sow Osteoarthrotic Cartilage Explants

Journal of Medicinal Food

Volumn 6, Issue 4, 2003, Pages 323-328

  Shen, Chwan Li ^a   Hong, Kee Jong ^a   Kim, Sung Woo ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

Cartilage; Ginger root; Nitric oxide; Osteoarthritis; Pigs; Prostaglandin E 2; Sows

Indexed keywords

ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; AQUARESIN GINGER; GINGER EXTRACT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTILAGE; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CYTOTOXICITY; EXPLANT; FEMALE; FOLLOW UP; GINGER; INFLAMMATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; SERUM; SWINE;

ANIMALIA; BOVINAE; CICONIIFORMES; SUS SCROFA; ZINGIBER; ZINGIBER OFFICINALE;

EID: 1642453609     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/109662003772519877     Document Type: Article

References (32)

1. Meat and Livestock Commission: Pig Yearbook 1980, Meat and Livestock Commission, London, 1980.
2. Meat and Livestock Commission: Pig Yearbook 1999, Meat and Livestock Commission, London, 2000.
3. PigChamp, 2001: Breeding Herd Summary. http://www.pigchampinc.com (accessed April 1, 2002).
4. Lucia T: Lifetime productivity of female swine [Ph.D. Thesis], University of Minnesota, St. Paul, 1997.
5. Paterson R, Cargill C, Pointon A: Investigations into deaths and excessive culling of sows in Autralian pig herds. In: Proceedings, Nordiska Jordbruksforskares Forening Seminar 265 - Longevity of Sows (Danielsen V, ed.), Denmark: Research Centre Foulum, Copenhagen, 1996, pp. 34-45.
6. Reiland S: Pathology of so-called leg weakness in the pig. Acta Radiol Suppl 1978;358:23-44.
7. Dijkhuisen AA, Krabbenborg RMM, Huirne RBM: Sow replacement: a comparison of farmers' actual decisions and model recommendations. Livest Prod Sci 1989;23:207-218.
8. Hill MA: Economic relevance, diagnosis, and countermeasures for degenerative joint disease (osteoarthrosis) and dyschondroplasia (osteochondrosis) in pigs. J Am Vet Med Assoc 1990;197:254-259.
9. Nakano T, Aherne FX, Brennan JJ, Thompson JR: Effect of growth rate on the incidence of osteochondrosis in growing swine. Can J Anim Sci 1987;64:139-146.
10. Hill MA: Causes of degenerative joint disease (osteoarthrosis) and dyschondroplasia (osteochondrosis) in pigs. J Am Vet Med Assoc 1990;197:107-113.
11. Tew WP: Synovial fluid analysis: applications in equine joint injury and disease. In: Proceedings of the American Association of Equine Practitioners, American Association of Equine Practitioners, Lexington, KY, 1982, pp. 121-127.
12. Brennan JJ, Aherne FX: Effect of dietary calcium and phosphorus levels on performance, bone bending moment and the severity of osteochondrosis and lameness in boars and gilts slaughtered at 100 or 130 kg body weight. Can J Anim Sci 1986;66:777-790.
13. Roberts AJ, O'Brien ME, Subak-Sharpe G: Nutraceuticals, Perigee, New York, 2001, pp. 461-463.
14. Srivastava KC, Mustafa T: Ginger (Zingiber officinale) and rheumatic disorders. Med Hypotheses 1989;29:25-28.
15. Srivastava KC, Mustafa T: Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses 1992;39:342-348.
16. Sharma JN, Srivastava KC, Gan EK: Suppressive effects of eugenol and ginger oil on arthritic rats. Pharmacology 1994;49:314-318.
17. 15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
18. Little CB, Flannery CR, Hughes CR, Mort JS, Roughley PJ, Dent C, Caterson B: Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999;344:61-68.
19. Little CB, Hughes CR, Curtis CL, Jones SA, Caterson B, Flannery CR: Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage. Arthritis Rheum 2002;46:124-129.
20. Blot L, Marcelis A, Devogelaer JP, Manicourt DH: Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage. Br J Pharmacol 2000;131:1413-1421.
21. Shen CL, Graham S, Morgan DL, Oetama B, Brewton L, Marshall MP, Lai TY, Chen YS, Chang YH: Effects of Chinese herbal remedy Schisandra arisanensis Hayata on aggrecans, morphology, and production of inflammatory mediators by human osteoarthritic chondrocytes and synoviocytes. Am J Tradit Chin Med 2002;3:53-63.
22. LeGrand A, Fermor B, Fink C, Pisetsky DS, Weinberg JB, Vail TP, Guilak F: Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum 2001;44:2078-2083.
23. Mustafa T, Srivastava KC: Possible leads for arachidonic acid metabolism altering drugs from natural products. J Drug Dev 1990;3:47-60.
24. Botany (2000) - Asia Zingiberacai Workshop. Program and Abstracts, Prince of Songkla University, Hat Yai, Thailand, October 15-18, 1991.
25. Srivastava KC, Mustafa T: Spices: antiplatelet activity and prostanoid metabolism. Prostaglandins Leukot Essent Fatty Acids 1989;39:255-266.
26. Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M: The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids 2002;67:475-478.
27. Flynn DL, Rafferty MF, Bactor AM: Inhibition of human neutrophil 5-lipooxygenase activity by gingerdione, shogoal, capsicin and related pungent compounds. Prostaglandins Leukot Med 1986;24:195-198.
28. Von Rechenberg B, McIlwraith CW, Akens MK, Frisbie DD, Leutenegger C, Auer JA: Spontaneous production of nitric oxide (NO), prostaglandin (PGE2) and neutral metalloproteinases (NMPs) in media of explant cultures of equine synovial membrane and articular cartilage from normal and osteoarthritic joints. Equine Vet J 2000;32:140-150.
29. Brandt KD, Smith G, Kang SY, Myers S, O'Connor B, Albrecht M: Effects of diacerein in an accelerated canine model of osteoarthritis. Osteoarthritis Cartilage 1997;5:438-439.
30. Yaron M, Shirazi I, Yaron I: Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Osteoarthritis Cartilage 1999;7:272-280.
31. Pelletier JP, Howell DS: Etiopathogenesis of osteoarthritis, arthritis and allied conditions. In: A Texbook of Rheumatology, Vol. 2 (McCarthy DJ, Koopman WJ, eds.), Lea and Febiger, Philadelphia, 1993, pp. 1723-1734.
32. Amin AR, Attur M, Abramson SB: Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr Opin Rheumatol 1999;11:202-209.